CBS 2019
CBSMD教育中心
中 文

Acute Coronary Syndrom

Abstract

Recommended Article

Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Cardiac Shock Care Centers: JACC Review Topic of the Week The prognostic role of mid-range ejection fraction in ST-segment elevation myocardial infarction Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing JACC Scientific Expert Panel OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP) New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy

Review Article2020 Jun 27;9(7):E2020.

JOURNAL: J Clin Med . Article Link

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome

W Bor, DA Gorog. Keywords: NOAC; ACS; antiplatelet therapy; antithrombotic therapy; atrial fibrillation; dual therapy; oral anticoagulants; percutaneous coronary intervention; triple therapy; vitamin K antagonist

Full Text PDF